- Home
- SABR vs CERT Comparison
SABR vs CERT Comparison
Compare SABR & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SABR | CERT |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 814.3M | 860.9M |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SABR | CERT |
|---|---|---|
| Price | $1.67 | $5.18 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 10 |
| Target Price | $1.50 | ★ $11.67 |
| AVG Volume (30 Days) | ★ 6.2M | 3.8M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 283.56 | 87.50 |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $3,866,956,000.00 | $418,838,000.00 |
| Revenue This Year | $7.51 | $4.18 |
| Revenue Next Year | $3.46 | $5.39 |
| P/E Ratio | $84.00 | ★ N/A |
| Revenue Growth | 7.46 | ★ 8.75 |
| 52 Week Low | $0.81 | $4.45 |
| 52 Week High | $3.46 | $13.88 |
Technical Indicators
Market Signals| Indicator | SABR | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 47.21 | 43.06 |
| Support Level | $1.49 | $4.45 |
| Resistance Level | $1.70 | $6.37 |
| Average True Range (ATR) | 0.12 | 0.32 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 35.80 | 16.67 |
Price Performance
Historical ComparisonAbout SABR Sabre Corporation
Sabre holds the number-two air booking volume share in the global distribution system industry. The distribution segment represented 80% of total 2025 revenue and airline IT solutions 20% of revenue. The company sold its growing hotel IT solutions division to TPG in 2025 for $960 million in net proceeds. Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.